• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX 0.00% 6.6¢

NOXOPHARM LIMITED

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel... Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NOX
strong buy interest
08:38 5 1.9K
08:38 Last post  Simo4006 Comments Created with Sketch.  5  Views Created with Sketch.  1.9K 
NOX 28/05/24 2 1.4K
28/05/24 Last post  Sirbrighton Comments Created with Sketch.  2  Views Created with Sketch.  1.4K 
NOX
Hudson Broadcast
27/05/24 1 686
Metals & Mining SECTOR NEWS

Ark Mines defines significant exploration target at Sandy Mitchell rare earths

AHK
02 Jul 2024
ARK MINES LIMITED
27/05/24 Last post  Sirbrighton Comments Created with Sketch.  1  Views Created with Sketch.  686 
NOX 17/05/24 6 3.1K
17/05/24 Last post  Footmax Comments Created with Sketch.  6  Views Created with Sketch.  3.1K 
NOX
News: NOX Noxopharm Ltd Says Scaling Up Production Of Its Preclinical SOF-SKN Lupus Medication
14/05/24 0 257
14/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  257 
NOX 08/05/24 5 2.1K
08/05/24 Last post  19661966 Comments Created with Sketch.  5  Views Created with Sketch.  2.1K 
NOX 19:36 35 16K
19:36 Last post  19661966 Comments Created with Sketch.  35  Views Created with Sketch.  16K 
NOX 04/04/24 0 400
04/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  400 

See All Discussions arrow Created with Sketch.

Timeline

Noxopharm joins global Alliance for mRNA Medicines
28 May 08:25
 
Milestone reached as SOF-SKN progresses to next level
14 May 08:20
 
March 2024 Quarterly Activities Report and Appendix 4C
29 Apr 08:29
 
Tour de Cure Grant for Brain Cancer Research
04 Apr 08:23
 
Appendix 4D and Half Year 2024 Financial Report
27 Feb 08:01
 
Noxopharm extends Hudson Institute strategic partnership
13 Feb 08:06
 
View More arrow Created with Sketch.
(20min delay)
Last
6.6¢
Change
0.000(0.00%)
Mkt cap ! $19.28M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 23214 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 12000 1
View Market Depth
Last trade - 16.12pm 02/07/2024 (20 minute delay) ?
Last
6.5¢
  Change
0.000 ( 4.41 %)
Open High Low Volume
6.5¢ 6.5¢ 6.5¢ 7000
Last updated 10.49am 02/07/2024 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.